1-(溴甲基)-2-氯-4-(三氟甲基)苯 | 279252-26-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1-(溴甲基)-2-氯-4-(三氟甲基)苯
• 英文名称: 1-(bromomethyl)-2-chloro-4-(trifluoromethyl)benzene
• 英文别名: 2-Chloro-4-(trifluoromethyl)benzyl bromide
• CAS: 279252-26-5
• 化学式: C₈H₅BrClF₃
• 分子量: 273.48
• InChiKey: AIZUUFYFLNVTQX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 海关编码：
  2903999090

反应信息

• 作为反应物：
  描述：

  1-(溴甲基)-2-氯-4-(三氟甲基)苯 生成 3-(2-Chloro-4-trifluoromethylbenzyl)-2,7-dimethyl-3H-imidazo[4,5-b]pyridine-5-carboxylic acid
  参考文献：
  名称：

  Sulfonamide compounds and medicinal use thereof

  摘要：

  化合物的化学式（I）为磺胺类化合物： R1—SO2NHCO—A—R2  （I） 其中R1为烷基，烯基，炔基等；A为除苯并咪唑基，吲哚基，4,7-二氢苯并咪唑基和2,3-二氢苯并噁嗪基之外的可选择取代的杂多环基团；X为烷基，氧杂环烷基等；R2为可选择取代的芳基，取代的联苯基等，其盐及包含其的药物组合物。该磺胺类化合物对于基于其降低血糖水平活性、cGMP-PDE（特别是PDE-V）抑制活性、平滑肌松弛活性、支气管扩张活性、血管扩张活性、平滑肌细胞抑制活性和抗过敏活性可治疗的疾病有效。

  公开号：

  US06348474B1
• 作为产物：
  描述：

  2-bromomethyl-3-chloro-5-iodo-benzene 生成 1-(溴甲基)-2-氯-4-(三氟甲基)苯
  参考文献：
  名称：

  IMIDAZOLE COMPOUNDS AND MEDICINAL USE THEREOF

  摘要：

  公开号：

  EP1142879B1

文献信息

• HETEROCYCLIC COMPOUNDS
  申请人：Hoffmann-La Roche Inc.

  公开号：US20210094973A1

  公开（公告）日：2021-04-01

  The invention provides new heterocyclic compounds having the general formula (I) wherein A, L 1 , X, m, n and R 1 to R 4 are as described herein, compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds.

  这项发明提供了具有一般式(I)的新杂环化合物，其中A、L1、X、m、n和R1至R4如本文所述，包括这些化合物的组合物、制造这些化合物的方法以及使用这些化合物的方法。
• Discovery, synthesis and evaluation of novel reversible monoacylglycerol lipase radioligands bearing a morpholine-3-one scaffold
  作者：Yingfang He、Luca C. Gobbi、Adrienne Müller Herde、Didier Rombach、Martin Ritter、Bernd Kuhn、Matthias B. Wittwer、Dominik Heer、Benoit Hornsperger、Charles Bell、Fionn O'Hara、Jörg Benz、Michael Honer、Claudia Keller、Ludovic Collin、Hans Richter、Roger Schibli、Uwe Grether、Linjing Mu

  DOI：10.1016/j.nucmedbio.2022.02.002

  日期：2022.5

  therapeutic target in the treatment of neuroinflammatory and neurodegenerative diseases, such as multiple sclerosis, Alzheimer's disease and Parkinson's disease. Development of MAGL-specific radioligands for non-invasive imaging by positron-emission tomography (PET) would deepen our knowledge on the relevant pathological changes in diseased states and accelerate drug discovery. In this study, we report

  单酰基甘油脂肪酶 (MAGL) 是一种丝氨酸水解酶，在脑内的内源性大麻素降解中起重要作用。它最近已成为治疗神经炎症和神经退行性疾病（如多发性硬化症、阿尔茨海默病和帕金森病）的有希望的治疗靶点。通过正电子发射断层扫描 (PET) 开发用于无创成像的 MAGL 特异性放射性配体将加深我们对疾病状态相关病理变化的了解并加速药物发现。在这项研究中，我们报告了两种吗啉-3-酮衍生物的选择和合成，作为潜在的可逆 MAGL PET 示踪剂候选物，基于它们的多参数优化分数。两种化合物 ([ 11 C] 1 , [ 11C] 2 ) 通过直接 [ 11 C]CO 2固定进行放射性标记，体外放射自显影研究证明了它们对 MAGL 的特异性和选择性。使用 MAGL 敲除和野生型小鼠的动态 PET 成像证实了[ 11 C] 2的体内特异性。我们的初步结果表明，morpholine-3-one 衍生物 [ 11 C]
• Malononitrile compounds and their use as pesticides
  申请人：——

  公开号：US20040138065A1

  公开（公告）日：2004-07-15

  The present invention relates to malononitrile compounds of formula 1 wherein R 1 and R 2 are the same or different and independently C 1 -C 5 (halo)alkyl, C 1 -C 5 (halo)alkyloxy, C 2 -C 5 (halo)alkenyl, C 2 -C 5 (halo)alkynyl, hydrogen, or cyano; R 3 is C 1 -C 3 haloalkyl, C 2 -C 4 haloalkenyl, or C 2 -C 4 haloalkynyl; m is an integer of 1 to 3; R 3 is halogen, cyano, nitro, C 1 -C 4 (halo)alkyl, or the like; n is an integer of 0 to 4, with the proviso that when n is 2 or more, then R 5 's are the same or different from each other; R 6 is hydrogen, halogen, cyano, nitro, C 1 -C 4 (halo)alkyl, or the like; as well as pesticide compositions containing these compounds as active ingredients. The present invention makes it possible to effectively control pests such as insect pests, acarine pests, and nematode pests.

  本发明涉及公式1的马隆腈化合物，其中R1和R2相同或不同且独立地为C1-C5（卤）烷基，C1-C5（卤）烷氧基，C2-C5（卤）烯基，C2-C5（卤）炔基，氢或氰基；R3为C1-C3卤代烷基，C2-C4卤代烯基或C2-C4卤代炔基；m为1到3的整数；R4为卤素，氰基，硝基，C1-C4（卤）烷基或类似物；n为0到4的整数，但当n为2或更多时，R5相互之间相同或不同；R6为氢，卤素，氰基，硝基，C1-C4（卤）烷基或类似物；以及含有这些化合物作为活性成分的杀虫剂组合物。本发明使得能够有效地控制昆虫害虫、螨虫和线虫害虫。
• Pesticide composition comprising malononitrile compounds
  申请人：——

  公开号：US20040142821A1

  公开（公告）日：2004-07-22

  The present invention relates to use of malononitrile compounds of formula (X): 1 wherein R 1 and R 2 are the same or different and independently C 1 -C 5 (halo)-alkyl, C 1 -C 5 (halo)alkyloxy, C 2 -C 5 (halo)alkenyl, C 2 -C 5 (halo)alkynyl, hydrogen, or cyano; R 3 and R 4 are the same or different and independently C 1 -C 10 alkyl, C 2 -C 10 alkenyl, C 2 -C 10 alkynyl, or hydrogen, or R 3 and R 4 are taken together to form C 2 -C 6 (halo)alkylene or C 4 -C 6 (halo)alkenylene; R 5 is halogen, cyano, nitro, C 1 -C 4 (halo)alkyl, or the like; n is an integer of 0 to 4; R 6 is halogen, cyano, nitro, C 1 -C 4 (halo)alkyl, or the like; or R 5 and R 6 are taken together to form methylenedioxy; with the provisos that when R 6 is hydrogen, then n is an integer of 1 to 4 and that when n is 2 or more, then R 5 's are different from each other; as pesticides, and to pesticide compositions containing these compounds as active ingredients. The present invention makes it possible to effectively control pests such as insect pests, acarine pests, and nematode pests.

  本发明涉及使用式（X）的丙二腈化合物：其中R1和R2相同或不同且独立地为C1-C5（卤）烷基，C1-C5（卤）烷氧基，C2-C5（卤）烯基，C2-C5（卤）炔基，氢或氰基；R3和R4相同或不同且独立地为C1-C10烷基，C2-C10烯基，C2-C10炔基或氢，或者R3和R4结合形成C2-C6（卤）烷基或C4-C6（卤）烯基；R5为卤素，氰基，硝基，C1-C4（卤）烷基或类似物；n为0至4的整数；R6为卤素，氰基，硝基，C1-C4（卤）烷基或类似物；或者R5和R6结合形成亚甲二氧基；但当R6为氢时，n为1至4的整数，且当n为2或更多时，R5不相同；作为杀虫剂，以及含有这些化合物作为活性成分的杀虫剂组合物。本发明使得能够有效地控制害虫，例如昆虫害虫，螨虫害虫和线虫害虫。
• Sulfonamide compounds and pharmaceutical use thereof
  申请人：Fujisawa Pharmaceutical Co. Ltd.

  公开号：US20020099212A1

  公开（公告）日：2002-07-25

  A sulfonamide compound of the formula (I): R 1 —SO 2 NHCO—A—X—R 2 (I) wherein R 1 is alky, alkenyl, alkynyl and the like; A is an optionally substituted heteropolycyclic group except benzimidazolyl, indolyl, 4,7-dihydrobenzimidazolyl and 2,3-dihydrobenzoxazinyl; X is alkylene, oxa, oxa(lower)alkylene and the like; and R 2 is optionally substituted aryl, substituted biphenylyl and the like, a salt thereof and a pharmaceutical composition comprising the same. The sulfonamide compound is effective for the diseases treatable based on their blood sugar level-depressing activity, cGMP-PDE (especially PDE-V)-inhibiting activity, smooth muscle relaxing activity, bronchodilating activity, vasodilating activity, smooth muscle cell suppressing activity, and antiallergic activity.

  化合物I的磺酰胺类化合物：R1-SO2NHCO-A-X-R2（I），其中R1是烷基，烯基，炔基等；A是可选取代的异杂多环基团，但不包括苯并咪唑基，吲哚基，4,7-二氢苯并咪唑基和2,3-二氢苯并噁唑基；X是烷基，氧杂环烷基，氧杂环（低）烷基等；R2是可选取代的芳基，取代联苯基等，其盐和药物组成物。该磺酰胺类化合物对于可基于其降低血糖水平的活性、cGMP-PDE（特别是PDE-V）抑制活性、平滑肌松弛活性、支气管扩张活性、血管扩张活性、平滑肌细胞抑制活性和抗过敏活性可治疗的疾病有效。